COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 173: Articles 1721-1730  | Next

Organizational resilience and its implications for healthcare workers in the COVID-19 pandemic: A literature review
Kaczmarski, K., Pasha, A., Inusah, A.-H., Li, X., Qiao, S.
10.1101/2024.10.10.24315244 — Posted: 2024-10-10
Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19
Wolday, D., Gebrehiwot, A., Rameto, M. A., Abdella, S., Gebreegziabher, A., Amogne, W., Hailu, M., Tollera, G., Tasew, G., Tessema, M., Rinke de Wit, T. F., Miler, M., Mukhreji, M., Gilgrass, A., Bowdish, D. M. E., Kaushic, C., Verschoor, C. P.
10.1101/2024.10.09.24315196 — Posted: 2024-10-10
Multi-ancestry GWAS of Long COVID identifiesimmune-related loci and etiological links to chronic fatigue syndrome, fibromyalgia and depression
Chaudhary, N. S., Weldon, C. H., Nandakumar, P., 23andMe Research Team, , Holmes, M. V., Aslibekyan, S.
10.1101/2024.10.07.24315052 — Posted: 2024-10-09
Structural basis of TMPRSS11D specificity and autocleavage activation
Fraser, B. J., Wilson, R. P., Ilyassov, O., Lac, J., Dong, A., Li, Y.-Y., Seitova, A., Li, Y., Hejazi, Z., Kenney, T. M. G., Penn, L. Z., Edwards, A., Morin, G. B., Benard, F., Arrowsmith, C. H.
10.1101/2024.10.09.617371 — Posted: 2024-10-09
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Completely Protective Multivalent Mucosal Dual Vaccine Against COVID-19 and Flu
Zhu, J., Sha, J., Batra, H., Jain, S., Wu, X., Hendrix, E., Kilgore, P. B., Sun, K., Plante, K. S., Plante, J. A., Walker, J., Tao, P., Chopra, A. K., Rao, V. B.
10.1101/2024.10.09.617418 — Posted: 2024-10-09
Genome-Wide Identification of Stable RNA Secondary Structures Across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics
Wang, J.
10.1101/2024.10.08.617329 — Posted: 2024-10-09
Mental health patterns and associated social determinants among university and college students in Sub-Saharan Africa during the COVID-19 pandemic era : A Scoping Review Protocol
MUTURIKI, M., Mapukata, N., Chauke, L., Jewett, S.
10.1101/2024.10.08.24315086 — Posted: 2024-10-08
Post-COVID-Syndrome patients might overestimate own cognitive impairment
Woehrstein, S., Matuz, T., Roetzer, L., Karnath, H.-O.
10.1101/2024.10.07.24314894 — Posted: 2024-10-07
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.
Cabel, C. R., Guzman, B. A., Alizadeh, E., Li, S., Holberg, C., Wichaidit, C., Cusanovich, D. A., Paek, A. L., Thatcher, G. R. J., Van Doorslaer, K., Nargi, R. S., Sutton, R. E., Suryadevara, N., Crowe, J. E., Carnahan, R. H., Thorne, C. A., Campos, S. K.
10.1101/2024.10.04.616743 — Posted: 2024-10-07
Chronic infections can generate SARS-CoV-2-like bursts of viral evolution without epistasis
Rodriguez-Horta, E., Strahan, J., Dinner, A., Barton, J. P.
10.1101/2024.10.06.616878 — Posted: 2024-10-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).